Drug recall · October 8, 2014
Diclofenac Sodium and Misoprostol Delayed-Release Tablets recall
Why: Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0398-60, UPC 3 05910 39860 6.
- Lots / codes
Lot #: 605956A, 605958A, Exp. 9/30/2014; 644678M, Exp. 10/31/2014; 661841A, Exp. 11/30/2014; 717469A, Exp 2/28/2015
- Quantity
- 36,538 bottles
- Company
- Actavis Laboratories, FL, Inc., Davie, FL
- Distribution
- Nationwide and Puerto Rico
- Initiated
- April 24, 2014 · Voluntary: Firm initiated
- Classified
- September 30, 2014
- Reported
- October 8, 2014
- Ended
- December 23, 2016
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diclofenac / misoprostol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.